Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ana Velasco Sanchez"'
Autor:
Serafin Morales Murillo, Ariadna Gasol Cud\\'S, Noemí Tuset Der-abrain, Alvaro Rodriguez, Ana Velasco Sanchez, Felip Vilardell, Douglas Sanchez Guzman, Carles Canosa Morales, Jordi Melé Olivé
Publikováno v:
Journal of Clinical Oncology. 40:e12608-e12608
e12608 Background: HER2-positive breast cancer is the more suitable subtype to perform a neoadjuvant therapy with chemotherapy and antiHER2 therapy because a high pathologic response and significance survival. However, despite this high percentage of
Autor:
Xavier Soria Gili, Ana Velasco Sanchez, Verónica Sanmartín Novell, José Manuel Fernández Armenteros, Elisa Martró Català, Nuria Arco Huguet, Rosa Maria Martí Laborda, Felip Vilardell Villellas
Publikováno v:
Pediatric bloodcancer. 65(7)
Langerhans cell histiocytosis (LCH) is a disorder characterized by accumulation of Langerhans-like cells in one or various organs. A correct staging work-up is essential since there are multiorgan presentations with a poor prognosis. We report three
Autor:
Serafin Morales, Anna Novell Alvarez, Ana Velasco Sanchez, Ariadna Gasol Cudós, Antonieta Salud Salvia, Anna Serrate Lopez
Publikováno v:
Journal of Clinical Oncology. 35:e12133-e12133
e12133 Background: Achieving a pathological complete response (pCR) in HER2 positive disease is a surrogate of survival. Several factors were studied in order to predict pCR, but only negative estrogen receptor is correlated to pCR. Methods: 168 pati
Autor:
Jose Vidal, Serafin Morales Murillo, Juan Carlos Samame Pérez-Vargas, Juan Felipe Cordoba Ortega, Anna Serrate Lopez, Antonio Llombar Cussac, Ana Velasco Sanchez, Joan Valls, Ariadna Gasol Cudós, Desamparados Moral, Xavier Matias-Guiu Guia, Ramon Gisbert, Antonieta Salud Salvia
Publikováno v:
The Breast. 24:S70-S71
Autor:
Antonieta Salud Salvia, Ana Velasco Sanchez, Serafin Morales Murillo, Maria Jose Panades Siurana, Ariadna Gasol Cudós, Elena Aguirre Ortega, Ana Serrate López
Publikováno v:
The Breast. 22:S51